BSEBoard Meeting6d ago · 3 Nov 2026, 06:16 pm
Advik Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2026 ,inter alia, to consider and approve The Un-Audited Financial Results of the Company & Limited Review Report thereon for the quarter and half year ended 30th September, 2026 and to carry on any other business with the permission of the Board.
Advik Laboratories Ltd · 531686
✦ AI SummaryResults
Advik Laboratories Ltd has scheduled a Board Meeting on 13/11/2026 to consider and approve the Un-Audited Financial Results for the quarter and half year ended 30th September, 2026.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Advik Laboratories Ltd - 531686 - Board Meeting Intimation for Notice Of Board Meeting To Consider The Un-Audited Financial Results Of The Company For The Quarter And Half Year Ended 30Th September, 2026
Attachments (1)
📄pdf
Download →
ff98c1b5-c6c0-4669-bb19-ff7b62558e26.pdf
View document text
MPS PHARMAA LIMITED
(FORMERLYADVIKLABORATORIESLIMIT
Dated: 03-11-2026
The Manager (Listing),
BSE Limited,
01st Floor, P.J.Towers
Dalal Street, Mumbai–400001
Sub: Notice of Board Meeting to consider the Un-Audited Financial Results of the company for the quarter and half
year ended 30th September, 2026
Ref: BSE Scrip Code 531686; ASEScripCode-01636 (ADVIKLABO)
Dear Sir/Madam,
Pursuant to Regulation 29 of the Securities and Exchange Board of India(LODR) Regulations, 2015, notice is hereby given that as per
the requirements of Regulation 33 of the Securities and Exchange Board of India (LODR) Regulations, 2015, a meeting of the Board
of Directors of the company is scheduled to be held on Friday, 13th November, 2026 at 03:00 P.M. at the corporate office of the
company at 703, Arunachal Building, 19, Barakhambha Road, Connaught Place, New Delhi-110001,to inter-alia, consider and
approve the Un-Audited Financial Results of the Company & Limited Review Report thereon for the quarter and half year ended
30th September, 2026 and to carry on any other business with the permission of the Board.
Further, pursuant to BSE Circular no. LIST/COMP/01/2019-20 dated April 02, 2019 and in accordance with Code of Conduct for
Prevention of Insider Trading framed by the Company pursuant to the SEBI (Prohibition of Insider Trading) Regulation, 2015, the
trading window for dealing in the shares of the Company for all Directors/Officers/Designated Employees of the Company and their
relatives, is already closed for the purpose of declaration of Un-Audited Financial Results for the quarter and half year ended 30th
September, 2026. Accordingly, the trading window of the company shall remain closed till 15th November, 2026.
This is for your information and records please.
Thanking You.
Yours Faithfully,
For MPS Pharmaa Limited
(Formerly Advik Laboratories Limited)
Peeyush Kumar Aggarwal
Managing Director
DIN: 00090423
The Manager (Listing)
Ahmedabad Stock Exchange Limited 01st
Floor, Kamdhenu Complex
Opp. Sahajanand College,
Panjara Pole, Ambawadi, Ahmedabad–380015
CINNo.:L74899HR1994PLC038300
CorporateOffice:703,Arunachalbuilding19,BarakhambaRoad,ConnaughtPlace,NewDelhi110001
Phones:011-42424884,43571040-45,Fax:011-43571047
Regd.Office&Factory:138.Roz-Ka-MeoIndustrialArea,Sohna -122103(Distt.Mewat),Haryana
Phones:0124-2362471Email:info@mpspharmaa.comWebsite:www.mpspharmaa.com